Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Xeris Pharmaceuticals Inc (NQ: XERS )

3.470 +0.110 (+3.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Xeris Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 Next >
4 Biggest Price Target Changes For Friday
SVB Leerink boosted the price target on Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) from $6 to $8. Xeris Biopharma shares rose 18.9% to $2.89 in pre-market trading.... 
Via Benzinga
Why Xeris Biopharma Shares Are Rising Today
Xeris Biopharma Holdings Inc (NASDAQ: XERS) is trading higher Friday morning after the company announced U.S. Food and Drug Administration approval of Recorlev for the... 
Via Benzinga
18 Stocks Moving in Friday's Pre-Market Session
Gainers Medalist Diversified REIT, Inc. (NASDAQ: MDRR) rose 34.3% to $1.37 in pre-market trading after the company reported a stock repurchase program of 500,000 shares. Xeris... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Edge Lower On Final Trading Day Of 2021
Pre-open movers U.S. stock futures traded slightly lower in early pre-market trade on the final trading day of 2021. The Dow Jones dropped around 90 points, snapping a six-session... 
Via Benzinga
5 Stocks To Watch For December 31, 2021
Some of the stocks that may grab investor focus today are: Medalist Diversified REIT, Inc. (NASDAQ: MDRR) reported a stock repurchase program of 500,000 shares. Medalist... 
Via Benzinga
Xeris Biopharma Announces U.S. FDA Approval of Recorlev® (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome
From Xeris Biopharma Holdings, Inc.
Via Business Wire
5 Beaten Down Biotech Stocks That Could Bounce Big In 2022
Biotech stocks remain poised to eke out modest gains for 2021 after the stellar gains of the previous year. COVID-19 drug and vaccine developers experienced volatility throughout... 
Via Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating... 
Via Benzinga
Xeris Biopharma Announces the Availability of Ogluo® in the UK Through Its Commercialization Partner, Tetris Pharma
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE: 
Via Benzinga
41 Stocks Moving In Monday's Mid-Day Session
Gainers Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3... 
Via Benzinga
70 Biggest Movers From Yesterday
Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The... 
Via Benzinga
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday! 
Via InvestorPlace
20 Stocks Moving in Monday's Pre-Market Session
Gainers Creative Realities, Inc. (NASDAQ: CREX) rose 132.9% to $3.40 in pre-market trading as the company reported a merger with Reflect Systems on Friday. Bit Brother Limited (... 
Via Benzinga
Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights
From Xeris Pharmaceuticals, Inc.
Via Business Wire
Xeris Biopharma to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 10, 2021
From Xeris Biopharma Holdings, Inc.
Via Business Wire
Why Xeris Pharmaceuticals Is Soaring 7% Higher Today
The biopharma is starting to put together a string of good news advances. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current volume of 7.2 million shares is 300.39% of Jaguar... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 28.64% to $2.47 during Monday's pre-market session. The company's market cap stands at $38.1 million.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021
Upgrades For Preferred Bank (NASDAQ: 
Via Benzinga
Xeris Pharmaceuticals Enters Collaboration Agreement With Merck
From Xeris Biopharma Holdings, Inc.
Via Business Wire
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Exposures Product Safety
45 Biggest Movers From Yesterday
Gainers Camber Energy, Inc.. (NYSE: CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial... 
Via Benzinga
Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma
From Xeris Pharmaceuticals, Inc.
Via Business Wire
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Xeris Pharmaceuticals, Inc.
Via Business Wire
Xeris Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
From Xeris Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Xeris Pharmaceuticals (NASDAQ:XERS 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.